At the cellular level, specific genetic and epigenetic alterations lead to changes in cellular signaling pathways, including the common inactivation of the TP53 tumor suppressor axis, thereby contributing to the blockade of differentiation and accumulation of leukemic blasts in the blood and bone marrow [1]. This evidence concerns the gene TP53 and neoplasm.